Glenmede Trust’s ViewRay, Inc. VRAY Stock Holding History

Glenmede Trust’s Portfolio VRAY Stock Details VRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,190	Closed	-$11K	–	2407
2020 Q3	$11K	Sell	3,190 -816	-20%	-$2.27K	﹤0.01%	1862
2020 Q2	$8K	Buy	+4,006	New	+$8.55K	﹤0.01%	1966

Other funds holding VRAY

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Glenmede Trust's VRAY Position: Q4 2020 in Review

Glenmede Trust sold out of ViewRay, Inc. (VRAY) in Q4 2020, closing a stake of 3,190 shares — an estimated $11K sold.

Glenmede Trust first reported a position in VRAY in Q2 2020 and held it in 2 quarters. The position peaked at $11K in Q3 2020. 119 funds tracked by Wall St. Rank hold VRAY as of Q4 2020.

Glenmede Trust reported no remaining ViewRay, Inc. position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 3,190 ViewRay, Inc. shares in Q4 2020, an estimated $11K.
Glenmede Trust first reported a position in ViewRay, Inc. in Q2 2020 and held it in 2 quarters.
Glenmede Trust's ViewRay, Inc. position peaked at $11K in Q3 2020.
119 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.